Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Sports Illustrated Plans Layoffs After Losing Right to Brand Name
Sports Illustrated's employee union said in a statement that the layoffs would be a significant number and possibly all, of the NewsGuild workers represented.
Japan Becomes Fifth Country to Reach the Moon
Officials said they aren't yet sure if the passenger-less spacecraft made a pinpoint landing, which was one of the mission's priorities.
Pinstripes Poised for Growth After Taking the Company Public
CEO and founder of Pinstripes Dale Schwartz shares his thoughts on taking the company public, why they're set for growth this year, and why he's not concerned about inflation weighing on the restaurant sector.
How Consumers Could See Artificial Intelligence in Their Daily Lives
With hype continuing to build for A.I. projects, expert insight on what companies seem poised to benefit, plus how it will impact the lives of everyday consumers.
Ford Cuts Production of F-150 Lightning Electric Truck
Ford says it’s reducing production of the F-150 Lightning electric pickup vehicle as it adjusts to weaker-than-expected electric vehicle sales growth. The automaker said about 1,400 workers will be impacted by the move.
How To Prepare For Home Renovations Without Breaking The Bank
Pro interior designers weigh in on updating your space.
Walmart raises starting pay for managers, average rate for hourly workers
Walmart Inc. is raising the starting base pay for store managers, while redesigning its bonus plan that will put more of an emphasis on profits for these leaders.
Federal Reserve Close to its Target Inflation Rate
What the latest economic data suggests about the strength of the consumer and the Fed's monetary policy in 2024.
How the Red Sea Shipping Crisis Could Impact U.S. Prices
Despite concerns about shipping delays in the Red Sea, RSM Chief Economist Joe Brusuelas says there are still reasons to be optimistic about the state of the U.S. economy.
